Conference Call and Webcast Scheduled for Tuesday, February 3, 2009
SAN DIEGO, Jan. 27 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.
(Nasdaq: NBIX) announced today that the Company will report its fourth quarter
and year-end 2008 financial results after the Nasdaq market closes on Tuesday,
February 3, 2009. Neurocrine will then host a live conference call and webcast
to discuss its financial results and provide a Company update Tuesday
afternoon, February 3, 2009 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific
Time).
Participants can access the live conference call by dialing 1-800-895-0198
(US) or 785-424-1053 (International) using the conference ID: 7NEURO. The call
can also be accessed via the webcast through the Company's website at
http://www.neurocrine.com
If you are unable to attend the Webcast and would like further information
on this announcement please contact the Investor Relations Department at
Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will
be available approximately one hour after the conclusion of the call by
dialing 1-800-388-9074 (US) or 402-220-1117 (International) using the
conference ID: 7NEURO. The call will be archived for two weeks.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on
neurological and endocrine diseases and disorders. Our product candidates
address some of the largest pharmaceutical markets in the world including
endometriosis, anxiety, depression, pain, diabetes, benign prostatic
hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and
endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news
releases are available through the Company's website via the internet at
http://www.neurocrine.com
SOURCE: Neurocrine Biosciences, Inc.
CONTACT:
Claudia Woodworth of Neurocrine Biosciences,
+1-858-617-7600
Web Site: http://www.neurocrine.com